The incidence and trends of proteinuria, azotemia and hypertension in cats receiving toceranib phosphate.
Kimberly WilliamsValerie MacDonald-DickinsonArata MatsuyamaPublished in: Journal of feline medicine and surgery (2024)
The incidence of proteinuria, renal azotemia and hypertension in cats treated with toceranib for neoplasia appears to be low. Toceranib may be a viable treatment option even in cats with pre-existing proteinuria or renal disease, with careful monitoring of trends recommended.
Keyphrases